PTM Therapeutics
Improving human health and well-being through the development of new therapeutics.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
* | N/A | - | |
| Total Funding | 000k | ||
PTM Therapeutics is a healthcare startup based in the San Francisco Bay Area. The company focuses on the development of therapeutic antibodies for the treatment of chronic diseases and cancer. Their unique approach is based on the concept of Post Translational Modifications (PTMs), which they believe can create more disease-specific targets for these therapeutic antibodies. In simpler terms, PTMs are changes made to proteins after they are formed, and PTM Therapeutics believes that these changes can be targeted to create more effective treatments.
The company operates in the healthcare and biotechnology market, serving patients suffering from chronic diseases and cancer. Their business model revolves around the discovery of new targets (PTMs) and the development of new therapeutics based on these targets. They generate revenue through the development and sale of these therapeutics.
PTM Therapeutics is also committed to promoting comprehensive healthcare access and diversity in the workplace. They oppose policies that restrict healthcare access or discriminate based on identity, as they believe these policies are detrimental to their business and the wider economy. They argue that such policies hinder their ability to build a diverse workforce, recruit top talent, and ensure the well-being of their employees.
Keywords: PTM Therapeutics, healthcare, biotechnology, therapeutic antibodies, Post Translational Modifications, chronic diseases, cancer, comprehensive healthcare access, diversity in the workplace, policy opposition.